Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | Choroby i zaburzenia | Choroby i zaburzenia |
| Evidence strength | Strong evidence | Strong evidence |
| Evidence Score | 4/5 | 4/5 |
| User rating | 4.6 (58) | 4.7 (68) |
| Typical dose | — | — |
| Form | — | — |
| Average price | — | — |
| Monthly cost | — | — |
| Time to effects | Quitting smoking doesn't reverse already-occurred tissue destruction, but significantly slows the further rate of FEV1 decline already within the first year after sustained cessation; pulmonary rehabilitation typically brings measurable improvement in exercise tolerance after 6–12 weeks of a regular program, and the effect of bronchodilators on breathlessness can be felt within days to weeks of starting treatment. | Densitometry measurements rarely show significant changes before several months — the network meta-analysis indicates that interventions lasting 52 weeks or longer produce more consistent, lasting effects than shorter programs. |
| Who it's for | Current and former long-term smokers with progressive exertional breathlessness or chronic cough | Perimenopausal and postmenopausal women |